GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,798 | -13.8% | 44,532 | 0.0% | 0.00% | – |
Q2 2023 | $77,486 | -7.9% | 44,532 | -33.3% | 0.00% | – |
Q1 2023 | $84,149 | +37299.6% | 66,785 | -10.1% | 0.00% | – |
Q4 2022 | $225 | -99.9% | 74,278 | -72.6% | 0.00% | – |
Q1 2022 | $309,000 | -62.0% | 271,129 | -52.0% | 0.00% | – |
Q4 2021 | $813,000 | -59.0% | 564,388 | -37.6% | 0.00% | -100.0% |
Q3 2021 | $1,981,000 | -27.6% | 904,628 | -23.3% | 0.00% | 0.0% |
Q2 2021 | $2,735,000 | -25.2% | 1,178,938 | -2.9% | 0.00% | 0.0% |
Q1 2021 | $3,656,000 | -19.5% | 1,214,587 | +0.5% | 0.00% | -50.0% |
Q4 2020 | $4,543,000 | +23.6% | 1,208,120 | +0.9% | 0.00% | 0.0% |
Q3 2020 | $3,675,000 | -17.0% | 1,196,925 | +1.6% | 0.00% | 0.0% |
Q2 2020 | $4,430,000 | +65.3% | 1,178,130 | +0.2% | 0.00% | +100.0% |
Q1 2020 | $2,680,000 | -51.7% | 1,175,331 | +12.0% | 0.00% | -50.0% |
Q4 2019 | $5,549,000 | +23.8% | 1,048,953 | +0.9% | 0.00% | 0.0% |
Q3 2019 | $4,482,000 | -61.9% | 1,039,745 | +5.3% | 0.00% | -60.0% |
Q2 2019 | $11,768,000 | +8.9% | 987,289 | +13.9% | 0.01% | +25.0% |
Q1 2019 | $10,803,000 | +84.8% | 866,962 | +40.4% | 0.00% | +33.3% |
Q4 2018 | $5,847,000 | +4.4% | 617,420 | +58.8% | 0.00% | +50.0% |
Q3 2018 | $5,598,000 | – | 388,756 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 3,229,856 | $45,186,000 | 5.74% |
NEA Management Company, LLC | 8,584,128 | $120,092,000 | 4.21% |
NEXTHERA CAPITAL LP | 321,286 | $4,495,000 | 1.16% |
Redmile Group, LLC | 1,214,088 | $16,985,000 | 0.84% |
EAM Investors, LLC | 371,030 | $5,191,000 | 0.69% |
Schonfeld Strategic Advisors LLC | 500,104 | $6,996,000 | 0.64% |
ELEMENT CAPITAL MANAGEMENT LLC | 29,909 | $418,000 | 0.17% |
Jafra Capital Management LP | 16,839 | $236,000 | 0.09% |
PRENTISS SMITH & CO INC | 20,000 | $280,000 | 0.08% |
Endurant Capital Management LP | 17,607 | $246,000 | 0.08% |